Invion Limited

ASX:IVX.AX

0 (AUD) • At close September 16, 2024
Bedrijfsnaam Invion Limited
Symbool IVX.AX
Munteenheid AUD
Prijs 0.002
Beurswaarde 13,533,180
Dividendpercentage 0%
52-weken bereik 0.002 - 0.008
Industrie Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Mr. Thian Chew
Website https://www.inviongroup.com

An error occurred while fetching data.

Over Invion Limited

Invion Limited, a clinical-stage life-sciences company, researches and develops photodynamic therapy for the treatment of various cancers in Australia. The company is developing IVX-PDT, a photosensitizer agent to treat skin cancers, as well as solid cancers, including lung, prostrate, ovarian, and mesothelioma cancers. It has a research and development agreement

Vergelijkbare Aandelen

Doctor Care Anywhere Group PLC logo

Doctor Care Anywhere Group PLC

DOC.AX

0.068 AUD

CleanSpace Holdings Limited logo

CleanSpace Holdings Limited

CSX.AX

0.465 AUD

Micro-X Limited logo

Micro-X Limited

MX1.AX

0.054 AUD

Biotron Limited logo

Biotron Limited

BIT.AX

0.023 AUD

MedAdvisor Limited logo

MedAdvisor Limited

MDR.AX

0.4 AUD

Botanix Pharmaceuticals Limited logo

Botanix Pharmaceuticals Limited

BOT.AX

0.415 AUD

Emyria Limited logo

Emyria Limited

EMD.AX

0.04 AUD

Orthocell Limited logo

Orthocell Limited

OCC.AX

0.465 AUD

Microba Life Sciences Limited logo

Microba Life Sciences Limited

MAP.AX

0.175 AUD

Financiële Gegevens

Cijfers zijn in miljoenen (AUD)

Cijfers zijn in miljoenen (AUD)